• Explore /
  • Poster
  • / Real-world assessment of capecitabine and oxaliplatin (CAPOX) tolerability in patients with localized colorectal cancer undergoing curative-intent therapy: A comprehensive single institution analysis.

Real-world assessment of capecitabine and oxaliplatin (CAPOX) tolerability in patients with localized colorectal cancer undergoing curative-intent therapy: A comprehensive single institution analysis.

Abstract Poster

Authors

null

Veronica Mears

Department of Pharmacy Services, University Hospitals Cleveland Medical Center, Cleveland, OH

Veronica Mears , Nikolas Naleid , Hanna Kakish , J. Eva Selfridge , Madison Conces , Melissa Amy Lumish , David L Bajor , Amit Mahipal , Sakti Chakrabarti

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Symptoms, Toxicities, and Whole-Person Care

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 90)

DOI

10.1200/JCO.2024.42.3_suppl.90

Abstract #

90

Poster Bd #

F13

Abstract Disclosures

Similar Posters

First Author: Haeseong Park

First Author: Samuel J Klempner

First Author: Jerod J Sears

First Author: Patricio Eduardo Yanez